"Drug Hypersensitivity" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Immunologically mediated adverse reactions to medicinal substances used legally or illegally.
| Descriptor ID |
D004342
|
| MeSH Number(s) |
C20.543.206 C25.100.468
|
| Concept/Terms |
Drug Hypersensitivity- Drug Hypersensitivity
- Drug Hypersensitivities
- Hypersensitivities, Drug
- Drug Allergy
- Allergies, Drug
- Drug Allergies
- Hypersensitivity, Drug
- Allergy, Drug
|
Below are MeSH descriptors whose meaning is more general than "Drug Hypersensitivity".
Below are MeSH descriptors whose meaning is more specific than "Drug Hypersensitivity".
This graph shows the total number of publications written about "Drug Hypersensitivity" by people in this website by year, and whether "Drug Hypersensitivity" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 1 | 2 |
| 1999 | 0 | 1 | 1 |
| 2000 | 3 | 1 | 4 |
| 2001 | 0 | 1 | 1 |
| 2003 | 5 | 0 | 5 |
| 2004 | 2 | 0 | 2 |
| 2005 | 1 | 3 | 4 |
| 2006 | 2 | 1 | 3 |
| 2007 | 1 | 2 | 3 |
| 2008 | 2 | 0 | 2 |
| 2009 | 0 | 1 | 1 |
| 2010 | 1 | 1 | 2 |
| 2011 | 1 | 1 | 2 |
| 2014 | 0 | 1 | 1 |
| 2015 | 5 | 3 | 8 |
| 2016 | 5 | 1 | 6 |
| 2017 | 2 | 0 | 2 |
| 2018 | 4 | 3 | 7 |
| 2019 | 2 | 1 | 3 |
| 2020 | 4 | 0 | 4 |
| 2021 | 1 | 0 | 1 |
| 2022 | 3 | 0 | 3 |
| 2023 | 3 | 0 | 3 |
| 2024 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug Hypersensitivity" by people in Profiles.
-
Antiseizure medication-induced hypersensitivity reactions: Data from a large healthcare system. Seizure. 2024 Nov; 122:172-178.
-
A penicillin allergy stewardship team to address unconfirmed pediatric penicillin allergies in Houston, Texas. Ann Allergy Asthma Immunol. 2024 Dec; 133(6):689-695.e3.
-
Patient-Reported Outcome Measures in Food and Drug Allergy. J Allergy Clin Immunol Pract. 2024 Oct; 12(10):2591-2598.
-
High-dose oxaliplatin induces severe hypersensitivity reactions and high recurrence rates during rechallenge in patients treated with hepatic arterial infusion chemotherapy. Int Immunopharmacol. 2024 Mar 30; 130:111767.
-
Delabeling antibiotic allergy: real-world experience from a pediatric cohort. Ann Allergy Asthma Immunol. 2023 10; 131(4):530-531.
-
The Quality and Management of Penicillin Allergy Labels in Pediatric Primary Care. Pediatrics. 2023 03 01; 151(3).
-
Impact of Penicillin Allergy Labels on Children Treated for Outpatient Respiratory Infections. J Pediatric Infect Dis Soc. 2023 Feb 27; 12(2):92-98.
-
Recombinant Erwinia asparaginase (JZP458) in acute lymphoblastic leukemia: results from the phase 2/3 AALL1931 study. Blood. 2023 02 16; 141(7):704-712.
-
Heterogeneity of Drug Allergies and Reaction Lists in Two U.S. Health Care Systems' Electronic Health Records. Appl Clin Inform. 2022 05; 13(3):741-751.
-
Allergy Safety Events in Health Care: Development and Application of a Classification Schema Based on Retrospective Review. J Allergy Clin Immunol Pract. 2022 07; 10(7):1844-1855.e3.